| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Transformation Officer | Sr MD International &Optimiza
1 company
Vroman Ken is a Chief Transformation Officer at CME. Recent filings cover 0 purchases and 5 sales. Those positions are worth an estimated $4.9M at current prices.
Our model assigns Vroman Ken a below-average insider score of 43/100, based on 4 past trades. Over a 12-month horizon, 33.3% of those trades were profitable, with an average 12-month return of -1.5%.
Vroman Ken's largest disclosed position is in CME as Chief Transformation Officer, worth about $4.9M. The recent filings there lean toward selling, a net 15,962 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 12, 2026 | CME Cme Group Inc. | Chief Transformation Officer | Sell | 5,160 | $309.00 | $1,594,440.00 | -25.7% | -15.2% | - | |
| Feb 13, 2025 | CME Cme Group Inc. | Chief Transformation Officer | Sell | 5,066 | $250.00 | $1,266,500.00 | -23.3% | +6.5% | +21.2% | |
| Sep 12, 2022 | CME Cme Group Inc. | Chief Transformation Officer | Sell | 750 | $201.41 | $151,057.50 | -5.7% | -9.1% | +3.6% | |
| Nov 9, 2021 | CME Cme Group Inc. | Sr MD International &Optimiza | Sell | 445 | $220.00 | $97,900.00 | -3.3% | +11.5% | -20.3% | |
| Nov 2, 2020 | CME Cme Group Inc. | Sr MD International &Optimiza | Sell | 4,541 | $152.63 | $693,092.83 | -31.5% | - | - |